ArticleRNA (New York, N.Y.)2019

An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema.

Jingxuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.